PQIA.F RadNet Inc

Healthcare Biotechnology Frankfurt Exchange
67.68 EUR
Close of Nov 13, 2026
43.85 72.50
Market cap
EUR 5.33B
P/E
-
P/B
5.51x
ROE
-2.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PQIA.F undervalued?

Graham number

The Graham number of RadNet Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

RadNet Inc fundamental analysis

No fundamental analysis for RadNet Inc yet.

RadNet Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About RadNet Inc

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also …

Full company profile